used gene expression profile-interactive analysis (GEPIA), gene set enrichment analysis (GSEA), and tumor immune estimation resource (TIMER) to compare ACE2 expression between cancer and normal tissues and the correlation between ACE2 expression and immune invasion [40]. The gene discussed is ACE2; the disease is cancer.